Olaf Schermeier - Fresenius Medical Insider

Fresenius Medical Care AG Co KGAA -- USA Stock  

USD 101.18  0.005  0.0049%

Member of the Management Board for Global Research & Development

Dr. Olaf Schermeier is Chief Executive Officer for Global Research and Development, Member of the Management Board at Fresenius Medical Care AG Co. KGaA since March 1, 2013. Previously, he served as president of global RD for Draeger Medical, Luebeck, Germany
Age: 43  Executive Since 2013  Ph.D    
49 6172 609 0  http://www.freseniusmedicalcare.com
Schermeier has many years of experience in various areas of the health care industry, among others at Chariteclinic and Biotronik, Germany. He holds a doctorate degree in Computer Science from the Technische Universitaet Berlin and graduated from the University of Hannover in Electrical Engineering.

Management Efficiency

The company has return on total asset (ROA) of 6.11 % which means that it generated profit of $6.11 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.05 % meaning that it generated $13.05 on every $100 dollars invested by stockholders.
The company has accumulated 9.51 B in total debt with debt to equity ratio (D/E) of 71.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Fresenius Medical Care AG Co KGAA has Current Ratio of 1.2 suggesting that it is not liquid enough and may have problems to pay out its financial obligations in time and when they become due.

Similar Executives

Entity Summary

KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on OTC Market in USA.Fresenius Medical Care AG Co KGAA (FMCQF) is traded on OTC Market in USA. It is located in Else-Kr?ner Strasse 1 and employs 113,648 people.

Did you try this?

Run Insider Screener Now

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
Hide  View All  NextLaunch Insider Screener

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Fresenius Medical Care AG Co KGAA to your portfolio

Top Management

Fresenius Medical Care Leadership Team
Rolf Classon, Executive
Oliver Maier, President
Roberto Fuste, Executive
Walter Weisman, Executive
Ben Lipps, Chairman
Michael Brosnan, CFO
Pascale Witz, Executive
Bernd Fahrholz, Executive
Kent Wanzek, CEO
Deborah McWhinney, Executive
William Johnston, Executive
Olaf Schermeier, Executive, Ph.D
Dominik Heger, Executive
Dieter Schenk, Chairman
William Valle, CEO
Rice Powell, Chairman
Ronald Kuerbitz, CEO
Harry Wit, CEO
Dominik Wehner, Executive
Gerd Krick, Chairman

Stock Performance

Fresenius Medical Performance Indicators